Compare Allbirds Inc (BIRD) vs Sana Biotechnology Inc (SANA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Allbirds Inc vs Sana Biotechnology Inc — how do they compare? Allbirds Inc trades at $2.59 (market cap $30.00M), while Sana Biotechnology Inc trades at $3.85 (market cap $1.13B). The key difference: Sana Biotechnology Inc is far larger — about 37.7× Allbirds Inc's market cap, and Sana Biotechnology Inc is trading nearer its 52-week high, Allbirds Inc nearer its low. Which is the better fit depends on your goals.
| BIRD | SANA | |
|---|---|---|
Market Cap | $30.00M | $1.13B |
Sector | Consumer Cyclical | Health |
52-Week High | $16.99 | $5.92 |
52-Week Low | $2.21 | $2.68 |
Enterprise Value | $48.86M | $1.05B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BIRD stock trades at $2.61, up 1.16% with a bullish technical signal despite mixed moving averages. The company has pivoted from footwear to AI infrastructure, rebranding as Smartbird in June 2026. Revenue declined from $298M in 2022 to $152M in 2025, with persistent negative net margins (-53.36%) and cash burn. Analyst consensus shows 21% buy ratings amid high hold percentage.
The outlook hinges on successful AI strategy execution, but significant risks include sustained losses, declining revenue, and cash flow challenges. Current valuation at P/S 0.15 appears low, yet profitability remains distant. Investors face binary outcome: AI pivot success could drive upside, while failure risks further declines.
SANA Biotechnology trades at $3.77, up 4.43% today, with a bullish technical signal from moving averages and ADX indicators. The company reported a net loss of $244.17 million for 2025, with negative cash flow from operations, but analyst consensus is strongly positive with 82% buy ratings. Recent news highlights clinical data presentations and a $9.50 average price target from brokerages as of July 30, 2026.
The outlook hinges on clinical progress driving future profitability, but high cash burn and negative ROE pose significant risks. Upside potential exists if pipeline milestones are met, supported by institutional optimism, though investors face volatility from earnings misses and funding needs.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Allbirds Inc
Allbirds Inc is a global lifestyle brand that innovates with naturally derived materials to make footwear and apparel products. Its primary source of revenue is from sales of shoes and apparel products in its directly owned digital and physical retail channels.
Read more on BIRD →About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →
